WESPAC Advisors SoCal’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-16
Closed – – 89
2019
Q1
$0 Hold
16
– – ﹤0.01% 332
2018
Q4
$0 Hold
16
– – ﹤0.01% 331
2018
Q3
$0 Buy
+16
New +$721 ﹤0.01% 304
2018
Q2
– Sell
-16
Closed – – 95
2018
Q1
$0 Hold
16
– – ﹤0.01% 268
2017
Q4
$1K Hold
16
– – ﹤0.01% 237
2017
Q3
$1K Hold
16
– – ﹤0.01% 250
2017
Q2
$1K Hold
16
– – ﹤0.01% 230
2017
Q1
$1.16K Hold
16
– – ﹤0.01% 238
2016
Q4
$938 Buy
+16
New +$845 ﹤0.01% 248

Other funds holding ADNT

WESPAC Advisors SoCal's ADNT Position: Q2 2019 in Review

WESPAC Advisors SoCal sold out of Adient (ADNT) in Q2 2019, closing a stake of 16 shares.

WESPAC Advisors SoCal first reported a position in ADNT in Q4 2016 and held it in 9 quarters. The position peaked at $1.16K in Q1 2017. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2019.

  • WESPAC Advisors SoCal reported no remaining Adient position as of Q2 2019 after selling out during the quarter.
  • WESPAC Advisors SoCal sold 16 Adient shares in Q2 2019.
  • WESPAC Advisors SoCal first reported a position in Adient in Q4 2016 and held it in 9 quarters.
  • WESPAC Advisors SoCal's Adient position peaked at $1.16K in Q1 2017.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2019, filed 30 Jul 2019.